Last reviewed · How we verify
Administration of Corneal Anesthesia
Approved treatments
- Tetracaine Hydrochloride · Alcon Labs
Tetracaine Hydrochloride works by blocking sodium channels in nerve cells to prevent pain signals from being transmitted. - Proxymetacaine · Medical University of Silesia
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Administration of Corneal Anesthesia patent landscape — cliff calendar, originator estates, attackable patents
- Administration of Corneal Anesthesia treatment landscape brief
- Administration of Corneal Anesthesia treatment updates RSS
Frequently asked questions about Administration of Corneal Anesthesia
What drugs treat Administration of Corneal Anesthesia?
Tracked treatments include Tetracaine Hydrochloride, Proxymetacaine.
What is the treatment for Administration of Corneal Anesthesia?
Standard treatment for Administration of Corneal Anesthesia includes Tetracaine Hydrochloride, Proxymetacaine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Administration of Corneal Anesthesia patent cliff · Administration of Corneal Anesthesia CI report
- Treatment: Tetracaine Hydrochloride · Alcon Labs
- Treatment: Proxymetacaine · Medical University of Silesia
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing